Gretel
Gretel, founded in 2019 and headquartered in the United States, operates in the synthetic data generation space, a market Gartner predicted would see 75% of businesses using generative AI to create synthetic customer data by 2026.
Profile
Gretel provides a platform for generating synthetic data—artificially created datasets that mimic real data—to help companies train AI models without exposing sensitive or proprietary information.
Gretel, founded in 2019 and headquartered in the United States, operates in the synthetic data generation space, a market Gartner predicted would see 75% of businesses using generative AI to create synthetic customer data by 2026. The company's platform is designed to produce high-quality, domain-specific synthetic data for training and evaluating AI models, particularly for agentic AI systems that require autonomous reasoning and action. Gretel's product portfolio includes tools for generating synthetic text, documents, and privacy-safe versions of sensitive data, with configurations aimed at meeting regulations like HIPAA and GDPR.
The company has integrated with NVIDIA's NeMo platform, as highlighted on NVIDIA's website, to accelerate agentic AI development. Financially, Gretel raised a $50 million Series B round in October 2021, as reported by TechCrunch, but no subsequent funding rounds or revenue figures have been publicly disclosed since then. The company's customer base includes enterprises in regulated industries such as healthcare, finance, and technology, though specific named clients are not provided in available sources.
Gretel's market position is as a specialized provider in a growing niche, competing with other synthetic data platforms and in-house solutions. As of mid-2026, the company's strategic focus appears to be on the agentic AI trend, leveraging partnerships like the one with NVIDIA to expand its reach. However, the lack of recent funding or revenue data raises questions about its growth trajectory and market traction relative to larger players in the AI infrastructure space.
Who buys this
- Healthcare organizations needing synthetic patient data for AI model training while complying with HIPAA
- Financial services firms using synthetic transaction data to develop fraud detection or risk models
- Technology companies building agentic AI systems that require diverse, domain-specific training datasets
- Enterprises in regulated industries seeking to share data internally or externally without privacy violations
Strengths and what to watch
Strengths
- Integration with NVIDIA NeMo platform positions Gretel within a major AI ecosystem, potentially expanding its reach to NVIDIA's customer base
- Privacy-focused synthetic data generation with built-in compliance configurations for HIPAA and GDPR addresses a critical pain point for regulated industries
- Product portfolio covers multiple data types (text, documents, structured data) and use cases (conversational AI, RAG evaluation, low-resource adaptation)
Watch for
- No publicly disclosed funding or revenue since the $50 million Series B in 2021, which may indicate slower growth or difficulty raising capital in a competitive market
- Reliance on the agentic AI trend as a primary market strategy could be risky if the hype cycle shifts or if larger competitors (e.g., from cloud providers) enter the synthetic data space
- Lack of named enterprise customers in available sources makes it hard to verify market traction or customer satisfaction beyond general claims
Key Information
- Industry
- Data Generation & Labelling
- Founded
- 2019
Frequently Asked Questions
What is Gretel and what does it do?
Gretel is a synthetic data generation platform founded in 2019. It creates artificial datasets that mimic real data, helping companies train AI models without exposing sensitive or proprietary information. The platform supports text, documents, and structured data for various AI use cases.
How does Gretel ensure privacy compliance with regulations like HIPAA and GDPR?
Gretel's platform includes built-in compliance configurations for HIPAA and GDPR, allowing enterprises in regulated industries like healthcare and finance to generate privacy-safe synthetic data. This enables sharing and model training without violating data protection laws.
What is Gretel's integration with NVIDIA NeMo?
Gretel has integrated with NVIDIA's NeMo platform to accelerate agentic AI development. This partnership positions Gretel within NVIDIA's ecosystem, potentially expanding its reach to NVIDIA's customer base for synthetic data generation tailored to autonomous AI systems.
What funding has Gretel raised and what does it indicate?
Gretel raised a $50 million Series B round in October 2021, as reported by TechCrunch. No subsequent funding or revenue has been publicly disclosed, which may suggest slower growth or challenges raising capital in a competitive synthetic data market.
What industries use Gretel's synthetic data platform?
Gretel serves enterprises in healthcare, finance, and technology, particularly those needing synthetic patient data for HIPAA-compliant AI training, synthetic transaction data for fraud detection, or diverse datasets for building agentic AI systems that require autonomous reasoning.
What are the risks associated with Gretel's market strategy?
Gretel's reliance on the agentic AI trend could be risky if the hype cycle shifts or if larger competitors like cloud providers enter the synthetic data space. The lack of named enterprise customers also makes it hard to verify market traction beyond general claims.
Sources
- gretel.ai — Company description, product focus on synthetic data generation for agentic AI, and integration with NVIDIA NeMo
- www.nvidia.com — NVIDIA's use case page featuring Gretel's synthetic data generation for agentic AI, including Gartner prediction and technical details
- techcrunch.com — TechCrunch report on Gretel's $50 million Series B funding round in October 2021
- www.prnewswire.com — Example of a non-Gretel financial report (Rigel Pharmaceuticals) included in the dossier; no direct relevance to Gretel